共 7 条
[1]
Local Production of Lipoprotein-Associated Phospholipase A2 and Lysophosphatidylcholine in the Coronary Circulation: Association With Early Coronary Atherosclerosis and Endothelial Dysfunction in Humans[J] . Shahar Lavi,Joseph P. McConnell,Charanjit S. Rihal,Abhiram Prasad,Verghese Mathew,Lilach O. Lerman,Amir Lerman.Circulation . 2007 (21)
[2]
Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial[J] . Michelle O’Donoghue,David A. Morrow,Marc S. Sabatine,Sabina A. Murphy,Carolyn H. McCabe,Christopher P. Cannon,Eugene Braunwald.Circulation . 2006 (14)
[3]
Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study[J] . Hok-Hay S. Oei,Irene M. van der Meer,Albert Hofman,Peter J. Koudstaal,Theo Stijnen,Monique M.B. Breteler,Jacqueline C.M. Witteman.Circulation . 2005 (5)
[5]
Lipoprotein-associated PLA 2 inhibition — a novel, non-lipid lowering strategy for atherosclerosis therapy[J] . Colin A Leach,Deirdre M.B Hickey,Robert J Ife,Colin H Macphee,Stephen A Smith,David G Tew.Il Farmaco . 2001 (1)
[6]
Lipoprotein-associated phospholipase A 2 , platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease[J] . Muriel J Caslake,Chris J Packard,Keith E Suckling,Stephen D Holmes,Paul Chamberlain,Colin H Macphee.Atherosclerosis . 2000 (2)
[7]
Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population[J] . Yoshiji Yamada,Hidemi Yoshida,Sahoko Ichihara,Tadaatsu Imaizumi,Kei Satoh,Mitsuhiro Yokota.Atherosclerosis . 2000 (1)